Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00233142 · ClinicalTrials.gov registry record · Phase 2
Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes Patients
A Phase 2 study, sponsored by Syracuse University.
- Completed
- Registry status
- Phase 2
- Development phase
- 187
- Enrollment target
NCT00233142 is a Phase 2 study that has completed, run by Syracuse University. The registered enrollment target is 187 participants.
The verdict
NCT00233142, a Phase 2 study, has completed, sponsored by Syracuse University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 187 participants
- Enrollment target
Study Summary
This study will determine whether the psychological benefits of expressive writing extend to diabetic patients, how long the benefits will last, and whether additional expressive writing "booster" sessions will lead to greater and more sustained improvement in diabetes symptoms and well-being.
Interventions
- BEHAVIORAL Expressive writing
- BEHAVIORAL Neutral writing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 187 participants |
| Start Date | 2005-09 |
| Est. Completion | 2009-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00233142
The ClinicalTrials.gov registry entry for NCT00233142 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 187 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Syracuse University, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Expressive writing is the first listed.
NCT00233142 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00233142 about?
NCT00233142 is a clinical study titled "Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes Patients". This study will determine whether the psychological benefits of expressive writing extend to diabetic patients, how long the benefits will last, and whether additional expressive writing "booster" sessions will lead to greater and more sustained improvement in diabetes symptoms and well-being.
What is the current status of trial NCT00233142?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 187 participants. The study started on 2005-09. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00233142?
The interventions under investigation include: Expressive writing (BEHAVIORAL), Neutral writing (BEHAVIORAL).
Who is sponsoring clinical trial NCT00233142?
This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.